Literature DB >> 6192840

Polypeptide clearing in model membranes: an analysis of the partition of gramicidin a' between cadmium ion induced gel and liquid-crystalline phases in vesicles of phosphatidic acid and phosphatidylcholine.

G W Feigenson.   

Abstract

Using a simple model for a biological membrane we examine cation-induced gel phase formation and the depletion of polypeptide from the gel phase. The model system consists of vesicles of phosphatidic acid and phosphatidylcholine which contain gramicidin A'. By use of electron spin resonance to monitor lipid phase behavior, Cd2+ is found to induce gel and liquid-crystal phase coexistence over a wide range of lipid composition. Quenching of gramicidin A' tryptophanyl fluorescence by spin-labeled phosphatidic acid or spin-labeled phosphatidylcholine is analyzed to obtain the partition coefficient, Kp, for gramicidin A' between gel and liquid-crystal phases. The value of Kp = 3 favoring the liquid-crystal phase indicates a partial clearing of the membrane-bound polypeptide from Cd2+-induced gel phase regions of the membrane.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192840     DOI: 10.1021/bi00282a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Influence of proteins on the reorganization of phospholipid bilayers into large domains.

Authors:  D M Haverstick; M Glaser
Journal:  Biophys J       Date:  1989-04       Impact factor: 4.033

2.  Uranyl acetate induces gel phase formation in model lipid and biological membranes.

Authors:  M Caffrey; S J Morris; G W Feigenson
Journal:  Biophys J       Date:  1987-09       Impact factor: 4.033

3.  Visualization of Ca2+-induced phospholipid domains.

Authors:  D M Haverstick; M Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Characterization of lipid domains in erythrocyte membranes.

Authors:  W Rodgers; M Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.